|4th January 2021||Wayne T Pan||1,089||Grant/award etc.||$0.00|
|4th January 2021||Cindy Moon||1,089||Grant/award etc.||$0.00|
|4th January 2021||Daniel S Messina||1,089||Grant/award etc.||$0.00|
|4th January 2021||Arthur N Leibowitz||1,089||Grant/award etc.||$0.00|
|28th December 2020||Douglas Murphy Chutorian||150||Open or private sale||$93.33||$13,999.50|
|28th December 2020||Douglas Murphy Chutorian||112||Open or private sale||$91.00||$10,192.00|
|28th December 2020||Douglas Murphy Chutorian||200||Open or private sale||$92.25||$18,450.00|
|28th December 2020||Douglas Murphy Chutorian||788||Open or private sale||$90.50||$71,314.00|
|21st December 2020||Douglas Murphy Chutorian||1,241||Open or private sale||$81.42||$101,041.10|
|21st December 2020||Douglas Murphy Chutorian||9||Open or private sale||$84.44||$760.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers' patients for chronic disease, including heart attacks and strokes. The company was founded by Herbert J. Semler and Shirley L.Semler on August 9, 2007.